… transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: …

… Manager of the Hematopoietic Stem Cell Transplant and CAR-T Cell Program of the Donostia University Hospital at San … assignments including stem cell transplant complications, CAR-T cell therapies, JACIE accreditation and data …

… 2024).  Recently, innovative cellular therapies (i.e. CAR-T cells, mesenchymal cells, Tregs-based therapies) have been … an update on the role of Chimeric Antigen Receptor (CAR) T-Cell Therapy in immune-mediated neurological diseases …

… importance to improve patient outcome following HCT or CAR-T therapy. The IDWP continues to enriching the knowledge on …

… Potential factors influencing CAR-T cell manufacturing in terms of production failures and out …

… to Cytokine Release Syndrome and Neurotoxicity with CAR T-cell Therapy Submitted by : Syed Ali Abutalib and Nicolaus … her good performance status, you offered her the option of CAR (chimeric antigen receptor) T cell therapy which she …

… for and delivered mostly by nurses. These covered the ITC, CAR-T and Mid Term Focus meetings of 2020. We are launching … the past 5 years. Haplo-identical transplantation and now CAR-T for instance are commonplace rather than experimental …

… Claire is Clinical research fellow in Paediatric BMT, CAR-T and Stem Cell Gene Therapy, Manchester University NHS … Other talks in the Trainee Day will include one on “CAR T toxicity for trainees” by Claire Roddie, Assistant …

… discussion involving Immune Effector Cells, which include CAR-T cell applications, was especially relevant in the current …

… the latest key articles from the Journal: Two for one? CAR-T therapy for lymphoma benefits concurrent autoimmune …